DeadLock ransomware: Breaking down a Rust-based encryptor with decentralized recovery infrastructure
Microsoft Threat Intelligence examines DeadLock ransomware, an emerging financially motivated operation distinguished by its ...
BOSTON – An experimental one-time gene therapy developed by Encoded Therapeutics reduced seizures and improved neurodevelopmental outcomes for children with Dravet syndrome, researchers reported ...
Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. BOSTON — A medicine increasingly used to ...
– NociPro enables highly selective nociceptor targeting and potent Na V 1.7 knockdown in rodents and non-human primates, supporting development candidate ETX301 for post‑amputation neuroma pain – – ...
– ETX301 nominated as a development candidate for post-amputation neuroma pain, with a planned IND submission in 2027 – SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Encoded Therapeutics, Inc.
TTI-O: Reference implementation of a unified multiomics data format for genome, mass spectrometry and NMR spectroscopy, modeled on MPEG-G (ISO/IEC 23092) - TTI-O/docs/format-spec.md at main · ...
If you buy something from a Verge link, Vox Media may earn a commission. See our ethics statement.
I never thought smart home tech was for me. Maybe that’s because my introduction to it was largely centered around my friends incessantly yelling “Hey Google!” whenever they wanted a light turned on ...
– Designation recognizes the potential of ETX101 to address a serious condition with high unmet need – SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--#Dravetsyndrome--Encoded Therapeutics, Inc.
ESET researchers examined CVE‑2025‑50165, a serious Windows vulnerability described to grant remote code execution by merely opening a specially crafted JPG file – one of the most widely used image ...
Encoded Therapeutics has linked its Dravet syndrome gene therapy ETX101 to a 78% reduction in seizures, keeping the biotech on track to start a pivotal study next year. The Californian company’s ...
We independently review everything we recommend. We may make money from the links on our site. Learn more› By Adrienne Maxwell Adrienne Maxwell is an editor covering AV gear. Her specialty is video ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results